Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-21

FDA Approved: NEVIRAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Nevirapine (generic) from Mylan Pharmaceuticals Inc., authorizing a modification to an existing approved product. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEVIRAPINE (nevirapine)

Snippet

SUPPL AP for NEVIRAPINE (NEVIRAPINE)